Citations

Clear

249 citation(s) found for "St-Denis, L".

Activity of oral irinotecan (IRI) in metastatic breast cancer (MBC) patients after prior anthracycline, taxane and capecitabine: Phase 2 study results
Vukelja, S., O’Shaughnessy, J., Blum, JL, Yardley, DA , Mainwaring, Paul N. , Senecal, Frank M., Benner, Rebecca, Denis, L., Pérez, E., Vukelja, Svetislava J., Campos-Gómez, Saúl , Vahdat, Linda T.

Mayo Clinic

Journal of Clinical Oncology | February 23, 2017 | Volume: 23 | Issue: 16_suppl | Pages: 562-562

10.1200/jco.2005.23.16_suppl.562 Get It

Soluble TREM2 induces inflammatory responses and enhances microglial survival
Zhong, Li , Chen, Xiao‐Fen , Liao, Chunyan , Huang, Ruizhi, Wang, Daxin , Wu, Linbei, Jia, Lin , Zheng, Honghua , Painter, Meghan M. , Atagi, Yuka, Liu, Chia‐Chen , Zhang, Yun‐wu , Fryer, John Denis , Xu, Huaxi , Bu, Guojun , Painter, Meghan , Atagi, Yuka , Liu, Chia-Chen , Fryer, John D., Wang, Tingting , Wang, Zhe , Wang, Zongqi , Li, Xinxiu , Bu, Guojun

Mayo Clinic

Journal of Experimental Medicine | February 16, 2017 | Volume: 214 | Issue: 3 | Pages: 597-607

10.1084/jem.20160844 | PMID 28209725 Get It

Triggering receptor expressed on myeloid cells 2 (TREM2) is an innate immune receptor expressed in microglia in the brain. A soluble form of TREM2 (sTREM2) derived from proteolytic cleavage of the cell surface receptor is increased in the preclinical stages of AD and positively correlates with the amounts of total and phosphorylated tau in the cerebrospinal fluid. However, the physiological and pathological functions of sTREM2 remain unknown. Here, we show that sTREM2 promotes microglial survival in a PI3K/Akt-dependent manner and stimulates the production of inflammatory cytokines depending on NF-κB. Variants of sTREM2 carrying AD risk-associated mutations were less potent in both suppressing apoptosis and triggering inflammatory responses. Importantly, sTREM2 delivered to the hippocampi of both wild-type and Trem2-knockout mice elevated the expression of inflammatory cytokines and induced morphological changes of microglia. Collectively, these data indicate that sTREM2 triggers microglial activation inducing inflammatory responses and promoting survival. This study has implications for the pathogenesis of AD and provides insights into targeting sTREM2 pathway for AD therapy.
Transethnic genome‐wide scan identifies novel Alzheimer's disease loci
Jun, Gyungah , Chung, Jaeyoon , Beecham, Gary W. , Bennett, David A. , Buxbaum, Joseph D. , Byrd, Goldie S. , Carrasquillo, Minerva M., Crane, Paul K. , Cruchaga, Carlos , Jager, Philip L. De , Ertekin‐Taner, Nilüfer , Evans, Denis A., Fallin, M. Danielle, Friedland, Robert P. , Goate, Alison , Graff‐Radford, Neill R. , Hendrie, Hugh C. , Hall, Kathleen, Hamilton‐Nelson, Kara L., Kukull, Walter A. , Kunkle, Brian W. , Kuwano, Ryozo, Larson, Eric B., Martin, Eden R. , Montine, Thomas J. , Reiman, Eric M. , Reitz, Christiane, Sherva, Richard , George‐Hyslop, Peter St , Thornton, Timothy, Younkin, Steven G., Wang, Li‐San , Wendlund, Jens R., Winslow, Ashley R. , Adams, Perrie M. , Albert, Marilyn S. , Albin, Roger L. , Apostolova, Liana G. , Arnold, Steven E. , Asthana, Sanjay , Atwood, Craig , Barmada, Michjael M, Beach, Thomas G. , Bigio, Eileen H. , Bird, Thomas D., Blacker, Deborah , Bowen, James D. , Boxer, Adam, Cairns, Nigel J. , Cao, Chuanhai , Carlson, Chris , Carlsson, Cynthia M., Carney, Regina M., Carroll, Steven L. , Chui, Helena C., Clark, David G., Corneveaux, Jason J., Cribbs, David H. , DeKosky, Steven T. , Demirci, F. Yesim , Dick, Malcolm, Doody, Rachelle S., Duara, Ranjan , Faber, Kelley , Fairchild, Thomas, Fallon, Kenneth B., Farlow, Martin R. , Frosch, Matthew P. , Gearing, Marla , Geschwind, Daniel H. , Gilbert, John R., Glass, Jonathan D. , Growdon, John H., Håkonarson, Håkon , Hamilton, Ronald L. , Hardy, John , Harrell, Lindy E., Huentelman, Matthew J. , Hulette, Christine M., Jarvik, Gail P. , Jicha, Gregory A. , Jin, Lee‐Way, Karydas, Anna, Koo, Edward H. , Kowall, Neil W. , Kramer, Joel H. , LaFerla, Frank M. , Leverenz, James B. , Ge, Li , Lieberman, Andrew P. , Lin, Chiao‐Feng , Lyketsos, Constantine G. , Mack, Wendy J. , Marson, Daniel , Martiniuk, Frank , Mash, Deborah C. , Masliah, Eliezer , McCormick, Wayne C., McKee, Ann C. , Mesulam, Marsel, Miller, Carol A., Miller, Joshua W., Morris, John C. , Murrell, Jill R. , Olichney, John , Parisi, Joseph E., Partch, Amanda, Paulson, Henry L. , Peskind, Elaine R. , Petersen, Ronald , Pierce, Aimee, Poon, Wayne W. , Raj, Ashok , Raskind, Murray A. , Reisch, Joan, Ringman, John M. , Rosen, Howard J., Rosenberg, Roger N., Royall, Donald R., Sager, Mark A., Sano, Mary , Saykin, Andrew J. , Schneider, Lon S. , Smith, Amanda , Sonnen, Joshua A. , Tanzi, Rudolph E. , Thornton‐Wells, Tricia A., Trojanowski, John Q. , Troncoso, Juan C. , Vinters, Harry V. , Vonsattel, Jean Paul, Weıntraub, Sandra , Wishnek, Sarah, Woltjer, Randall L. , Wright, Clinton B., Wu, Chuang‐Kuo, Yu, Chang‐En , Yu, Lei , Haines, Jonathan L. , Mayeux, Richard , Pericak‐Vance, Margaret A. , Schellenberg, Gerard, Lunetta, Kathryn L. , Farrer, Lindsay A. , Bennett, David A. , Mez, Jesse , Barber, Robert C. , Carrasquillo, Minerva M. , Cruchaga, Carlos , Foroud, Tatiana , Hamilton‐Nelson, Kara L. , Inzelberg, Rivka , Kamboh, M. Ilyas , Kauwe, John S. K. , Logue, Mark W. , Manly, Jennifer J. , Mukherjee, Shubhabrata , Naj, Adam Christian , Sherva, Richard , Vardarajan, Badri Narayan , Barnes, Lisa L. , Becker, James T. , Boeve, Bradley F. , Burke, James R. , Carlsson, Cynthia M. , Chui, Helena C. , Crocco, Elizabeth , DeCarli, Charles , Dickson, Dennis W. , Duara, Ranjan , Ferris, Steven H. , Galasko, Douglas , Ghetti, Bernardino , Green, Robert C. , Head, Elizabeth , Honig, Lawrence S. , Huebinger, Ryan , Hyman, Bradley T. , Kaye, Jeffrey , Kim, Ronald , Lah, James J. , Levey, Allan I. , Li, Ge, López, Oscar L. , McCurry, Susan M. , McDavid, Andrew , Mesulam, Marsel M. , Miller, Bruce L. , Myers, Amanda , O’Bryant, Sid E. , Pankratz, V. Shane , Perry, William , Potter, Huntington , Quinn, Joseph F. , Reisberg, ‌Barry , Roberson, Erik D. , Rogaeva, Ekaterina A. , Schneider, Julie A. , Seeley, William W. , Spina, Salvatore , Stern, Robert A. , Tsuang, Debby W. , Deerlin, Vivianna M. Van , Eldik, Linda J. Van , Welsh-Bohmer, Kathleen Anne , Williamson, Jennifer , Zhang, Xiaoling , Hakonarson, Hakon , Saykin, Andrew J , Leverenz, James B , Jarvik, Gail P , Paulson, Henry L , Hardy, John , Morris, John C , Goate, Alison M , Jicha, Gregory A , Sonnen, Joshua

Mayo Clinic

Alzheimer's & Dementia | February 6, 2017 | Volume: 13 | Issue: 7 | Pages: 727-738

10.1016/j.jalz.2016.12.012 | PMID 28183528 Get It

Abstract Introduction Genetic loci for Alzheimer's disease (AD) have been identified in whites of European ancestry, but the genetic architecture of AD among other populations is less understood. Methods We conducted a transethnic genome‐wide association study (GWAS) for late‐onset AD in Stage 1 sample including whites of European Ancestry, African‐Americans, Japanese, and Israeli‐Arabs assembled by the Alzheimer's Disease Genetics Consortium. Suggestive results from Stage 1 from novel loci were followed up using summarized results in the International Genomics Alzheimer's Project GWAS dataset. Results Genome‐wide significant (GWS) associations in single‐nucleotide polymorphism (SNP)–based tests ( P < 5 × 10 −8 ) were identified for SNPs in PFDN1/HBEGF , USP6NL/ECHDC3 , and BZRAP1‐AS1 and for the interaction of the (apolipoprotein E) APOE ε4 allele with NFIC SNP. We also obtained GWS evidence ( P < 2.7 × 10 −6 ) for gene‐based association in the total sample with a novel locus, TPBG ( P = 1.8 × 10 −6 ). Discussion Our findings highlight the value of transethnic studies for identifying novel AD susceptibility loci.
The complex genetics of gait speed: genome-wide meta-analysis approach
Ben-Avraham, Dan, Karasik, David , Verghese, Joe , Lunetta, Kathryn L. , Smith, Jennifer A. , Eicher, John D., Vered, Rotem, Deelen, Joris , Arnold, Alice M. , Buchman, Aron S. , Faul, Jessica D. , Nethander, Maria , Fornage, Myriam , Adams, Hieab H.H. , Matteini, Amy M., Callisaya, Michele L. , Smith, Albert V. , Yu, Lei, Jager, Philip L. De , Evans, Denis A., Guðnason, Vilmundur , Hofman, Albert , Pattie, Alison, Knopman, Davis S., Parimi, Neeta, Bandinelli, Stefania , Beekman, Marian , Gutman, Danielle , Sharvit, Lital , Mooijaart, Simon P. , Liewald, David C. , Houwing‐Duistermaat, Jeanine J. , Ohlsson, Claes , Moed, Matthijs, Hernández, Dena , McWhirter, Rebekah , Thomson, Russell , Tranah, Gregory J. , Uitterlinden, André G. , Weir, David R. , Zhao, Wei , Starr, John M. , Johnson, Andrew D. , Bennett, David A. , Cummings, Steven R. , Deary, Ian J. , Harris, Tamara B., Kardia, Sharon L. R., Mosley, Thomas H. , Srikanth, Velandai , Windham, B. Gwen , Davies, Gail , Evans, Daniel S. , Ferrucci, Luigi , Atzmon, Gil , Bennett, David A. , Turner, Stephen T. , Tanaka, Toshiko , Corley, Janie , Launer, Lenore J. , Verlinden, Vincentius J.A. , Mellström, Dan , Geest, Jos N. van der , Karlsson, Magnus K , Liu, Ching‐Ti , Ikram, M. Arfan , Newman, Anne B. , Walston, Jeremy D , Slagboom, P. Eline , Kiel, Douglas P. , Murabito, Joanne M. , Smith, Jennifer A , Adams, Hieab H H , Smith, Albert V , Ferrucci, Luigi , Ohlsson, Claes , Srikanth, Velandai K

Mayo Clinic

Aging | December 30, 2016 | Volume: 9 | Issue: 1 | Pages: 209-246

10.18632/aging.101151 | PMID 28077804 Get It

MicroRNA-194 Promotes Prostate Cancer Metastasis by Inhibiting SOCS2
Gregory, Philip A. , Fernandes, Rayzel C. , Denis, Iza , Wang, Qingqing , Townley, Scott L. , Zhao, Shuang G. , Hanson, Adrienne R. , Pickering, Marie , Armstrong, Heather , Lokman, Noor A. , Ebrahimie, Esmaeil , Jenkins, Robert B. , Karnes, R. Jeffrey , Ross, Ashley E. , Den, Robert B. , Klein, Eric A. , Ramshaw, Hayley S. , Williams, Elizabeth D. , Zoubeidi, Amina , Goodall, Gregory J. , Feng, Felix Y. , Butler, Lisa M. , Tilley, Wayne D. , Selth, Luke A. , Das, Rajdeep , Townley, Scott L. , Zhao, Shuang G , Davicioni, Elai , N., Kim , Den, Robert B , Klein, Eric A

Mayo Clinic

Cancer Research | December 23, 2016 | Volume: 77 | Issue: 4 | Pages: 1021-1034

10.1158/0008-5472.can-16-2529 | PMID 28011622 Get It

Abstract Serum levels of miR-194 have been reported to predict prostate cancer recurrence after surgery, but its functional contributions to this disease have not been studied. Herein, it is demonstrated that miR-194 is a driver of prostate cancer metastasis. Prostate tissue levels of miR-194 were associated with disease aggressiveness and poor outcome. Ectopic delivery of miR-194 stimulated migration, invasion, and epithelial–mesenchymal transition in human prostate cancer cell lines, and stable overexpression of miR-194 enhanced metastasis of intravenous and intraprostatic tumor xenografts. Conversely, inhibition of miR-194 activity suppressed the invasive capacity of prostate cancer cell lines in vitro and in vivo. Mechanistic investigations identified the ubiquitin ligase suppressor of cytokine signaling 2 (SOCS2) as a direct, biologically relevant target of miR-194 in prostate cancer. Low levels of SOCS2 correlated strongly with disease recurrence and metastasis in clinical specimens. SOCS2 downregulation recapitulated miR-194–driven metastatic phenotypes, whereas overexpression of a nontargetable SOCS2 reduced miR-194–stimulated invasion. Targeting of SOCS2 by miR-194 resulted in derepression of the oncogenic kinases FLT3 and JAK2, leading to enhanced ERK and STAT3 signaling. Pharmacologic inhibition of ERK and JAK/STAT pathways reversed miR-194–driven phenotypes. The GATA2 transcription factor was identified as an upstream regulator of miR-194, consistent with a strong concordance between GATA2 and miR-194 levels in clinical specimens. Overall, these results offer new insights into the molecular mechanisms of metastatic progression in prostate cancer. Cancer Res; 77(4); 1021–34. ©2016 AACR.
Two novel loci, COBL and SLC10A2, for Alzheimer's disease in African Americans
Chung, Jaeyoon , Jun, Gyungah , Kriegel, Joshua, Bourlas, Alexandra P., Sherva, Richard , Barnes, Lisa L. , Bennett, David A. , Buxbaum, Joseph D. , Byrd, Goldie S. , Crane, Paul K. , Ertekin‐Taner, Nilüfer , Evans, Denis A., Fallin, M. Daniele , Goate, Alison , Graff‐Radford, Neill R. , Hall, Kathleen, Kukull, Walter A. , Larson, Eric B., Haines, Jonathan L. , Mayeux, Richard , Pericak‐Vance, Margaret A. , Schellenberg, Gerard D. , Lunetta, Kathryn L. , Farrer, Lindsay A. , Bennett, David A. , Mez, Jesse , Sherva, Richard , Logue, Mark W. , Foroud, Tatiana , Kamboh, M. Ilyas , Manly, Jennifer J. , Goate, Alison M , Barnes, Lisa L

Mayo Clinic

Alzheimer's & Dementia | October 20, 2016 | Volume: 13 | Issue: 2 | Pages: 119-129

10.1016/j.jalz.2016.09.002 | PMID 27770636 Get It

AbstractIntroductionAfrican Americans' (AAs) late‐onset Alzheimer's disease (LOAD) genetic risk profile is incompletely understood. Including clinical covariates in genetic analyses using informed conditioning might improve study power.MethodsWe conducted a genome‐wide association study (GWAS) in AAs employing informed conditioning in 1825 LOAD cases and 3784 cognitively normal controls. We derived a posterior liability conditioned on age, sex, diabetes status, current smoking status, educational attainment, and affection status, with parameters informed by external prevalence information. We assessed association between the posterior liability and a genome‐wide set of single‐nucleotide polymorphisms (SNPs), controlling for APOE and ABCA7, identified previously in a LOAD GWAS of AAs.ResultsTwo SNPs at novel loci, rs112404845 (P = 3.8 × 10−8), upstream of COBL, and rs16961023 (P = 4.6 × 10−8), downstream of SLC10A2, obtained genome‐wide significant evidence of association with the posterior liability.DiscussionAn informed conditioning approach can detect LOAD genetic associations in AAs not identified by traditional GWAS.
International Expert Consensus on Sutureless and Rapid Deployment Valves in Aortic Valve Replacement Using Minimally Invasive Approaches
Glauber, Mattia , Moten, Simon, Quaini, Eugenio, Meuris, Bart , Miceli, Antonio, Oberwalder, Peter, Rambaldini, Manfredo, Teoh, Kevin , Bhatnagar, Gopal , Borger, Michael A. , Bouchard, Denis , Bouchot, Olivier , Clark, Stephen , Dapunt, O., Ferrarini, Matteo , Fischlein, Theodor , Mignosa, Carmelo , Millner, Russell, Noirhomme, Philippe, Pfeiffer, Steffen, Ruyra-Baliarda, Xavier, Shrestha, Malakh , Suri, Rakesh M. , Troise, Giovanni , Geršak, Borut , Messina, Antonio , Solinas, Marco , Folliguet, Thierry A , Miceli, Antonio , Laufer, Günther

Mayo Clinic

Innovations: Technology and Techniques in Cardiothoracic and Vascular Surgery | August 19, 2016 | Volume: 11 | Issue: 3 | Pages: 165-173

10.1097/imi.0000000000000287 | PMID 27540996 Get It

Objective To define the benefit of sutureless and rapid deployment valves in current minimally invasive approaches in isolated aortic valve replacement. Methods A panel of 28 international experts with expertise in both minimally invasive aortic valve replacement and rapid deployment valves was constituted. After thorough literature review, the experts rated evidence-based recommendations in a modified Delphi approach. Results No guideline could be retrieved. Thirty-three clinical trials and 9 systematic reviews could be identified for detailed text analysis to obtain a total of 24 recommendations. After rating by the experts 12, final recommendations were identified: preoperative computed to-mographic scan as well as intraoperative transesophageal echocardiography are highly recommended. Suitable annular sizes are 19 to 27 mm. There is a contraindication for bicuspid valves only for type 0 and for annular abscess or destruction due to infective endocarditis. The use of sutureless and rapid deployment valves reduces extracorporeal circulation and aortic cross-clamp time and leads to less early complications as prolonged ventilation, blood transfusion, atrial fibrillation, pleural effusions, paravalvular leakages and aortic regurgitation, and renal replacement therapy, respectively. These clinical outcomes result in reduced intensive care unit and hospital stay and reduced costs. The use of sutureless and rapid deployment valves will lead to a higher adoption rate of minimally invasive approaches in aortic valve replacement. Respect should be taken to a necessary short learning curve for both sutureless and minimally invasive programs. Conclusions Sutureless and rapid deployment aortic valve replacement together with minimally invasive approaches offers an attractive option in aortic valve placement for patients requiring biological valve replacement.
Clinical results of ultrasound bladder vibrometry for assessment of bladder compliance
Cheong, Mathew , Denis, Max , Gregory, Adriana , Nenadic, Ivan , Husmann, Douglas A. , Mynderse, Lance A. , Bayat, Mahdi , Kumar, Viksit , Mehrmohammadi, Mohammad , Alizad, Azra , Fatemi, Mostafa

Mayo Clinic

Journal of the Acoustical Society of America | May 6, 2016 | Volume: 139 | Issue: 4_Supplement | Pages: 2176-2176

10.1121/1.4950464 Get It

Healthy human bladder is a viscoelastic shell capable of expanding to allow storage of urine at low pressures. The ability to maintain low pressures as the urine volume increases is called bladder compliance. Compliance is a key in proper functioning of urinary system. Spinal cord injuries and other neurogenic diseases can cause deterioration in bladder expansion capability (e.g., through excessive growth of fibrotic tissue), which in turn can increase the rigidity of the wall and reduce bladder compliance. Urodynamic study (UDS) is the clinical standard for evaluation of the bladder compliance through observation of bladder pressure-volume behavior. However, this method is costly and invasive. Ultrasound bladder vibrometry (UBV) has been introduced as noninvasive technique for evaluation of bladder viscoelasticity through excitation of the bladder using ultrasound radiation force and tracking the resulting Lamb waves. Here, we present the results of UBV from 44 patients undergoing concurrent UDS and UBV studies. Our results show that elasticity parameters obtained from the UBV closely correlate with the UDS pressure-volume data with a median Pearson’s correlation value of more than 0.8. These results prove the potential utility of UBV as an alternative noninvasive method for bladder compliance assessment. [Work supported by NIH grant DK99231.]
Bone demineralization assessment using acoustic radiation force
Denis, Max , Wan, Leighton , Cheong, Mathew , Fatemi, Mostafa , Alizad, Azra

Mayo Clinic

Journal of the Acoustical Society of America | May 6, 2016 | Volume: 139 | Issue: 4_Supplement | Pages: 2028-2028

10.1121/1.4949983 Get It

In this work, an ultrasound-guided remote measurement technique is proposed for bone demineralization assessment. Utilizing an acoustic radiation force (ARF) beam as our excitation source and a receiving hydrophone, the mechanical properties of a bone can be noninvasively assessed. Focusing the ARF beam on the bone surface acts as point force generating vibrational waves. Coupling the bone surface and hydrophone, the ensuing radiating acoustic pressure from these vibrational waves are captured for analysis. Of particular interest, are the features best related to the bone’s mechanical properties. Conducting ex-vivo experiments demonstrated that the velocity feature best delineates intact and demineralized bones. The typical velocity of an intact bone (3000 m/s) is higher in comparison to a 72 h demineralized bone (1600 m/s). According to the receiver operating characteristic (ROC) curve, the optimal velocity cut-off value of 3096 m/s yields 80% sensitivity and 82.61% specificity between the intact and demineralized bones. Other features, such as the spectra of the demineralized bones’ acoustic response, exhibited higher attenuation for frequencies below 200 kHz in comparison to the intact bones. A time-frequency analysis demonstrated a frequency shift with demineralization. These results demonstrate the potential application of our proposed technique for monitoring bone demineralization.